의약품 관련 법령
Human Immunodeficiency Virus-1 Infection: Developing Systemic Drug Products for Pre-Exposure Prophylaxis
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-31 | 조회수 | 760 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM610623.pdf | ||
첨부파일 |
Human Immunodeficiency Virus-1 Infection: Developing Systemic Drug Products for Pre-Exposure Prophylaxis
- 이전글 Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry
- 다음글 S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers